

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.88045036 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.88045036 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.41510554 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.41510554 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.73547792 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.30021102 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.30021102 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.30021102 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.20876997 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.13983354 |
| 11 | regulation of protein activation cascade (GO:2000257) | 6.07017738 |
| 12 | exogenous drug catabolic process (GO:0042738) | 6.06785083 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.90430197 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.89043647 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.78432365 |
| 16 | regulation of fibrinolysis (GO:0051917) | 5.69983427 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66079361 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 5.61940017 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.54676168 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.53486155 |
| 21 | regulation of complement activation (GO:0030449) | 5.53236908 |
| 22 | regulation of apoptotic cell clearance (GO:2000425) | 5.40756519 |
| 23 | protein carboxylation (GO:0018214) | 5.35598143 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.35598143 |
| 25 | urea cycle (GO:0000050) | 5.25397331 |
| 26 | urea metabolic process (GO:0019627) | 5.25397331 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.18023485 |
| 28 | omega-hydroxylase P450 pathway (GO:0097267) | 5.15737107 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09743142 |
| 30 | cysteine metabolic process (GO:0006534) | 5.07551958 |
| 31 | imidazole-containing compound metabolic process (GO:0052803) | 4.90715692 |
| 32 | negative regulation of blood coagulation (GO:0030195) | 4.89383155 |
| 33 | negative regulation of hemostasis (GO:1900047) | 4.89383155 |
| 34 | bile acid metabolic process (GO:0008206) | 4.87963976 |
| 35 | regulation of humoral immune response (GO:0002920) | 4.86022474 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.83114921 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.80645240 |
| 38 | glutamate metabolic process (GO:0006536) | 4.77045668 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.74368236 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 4.73859050 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71791617 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.71791617 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.71791617 |
| 44 | positive regulation of blood coagulation (GO:0030194) | 4.70726422 |
| 45 | positive regulation of hemostasis (GO:1900048) | 4.70726422 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.70206038 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.70206038 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.69950079 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.67043055 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.65181716 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.64819608 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.62814407 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.58517295 |
| 54 | opsonization (GO:0008228) | 4.56187530 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.55115388 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.53724928 |
| 57 | negative regulation of coagulation (GO:0050819) | 4.46862191 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.44998242 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 4.44487841 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.43130479 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 4.37039768 |
| 62 | amine catabolic process (GO:0009310) | 4.37039768 |
| 63 | negative regulation of wound healing (GO:0061045) | 4.33701608 |
| 64 | phospholipid efflux (GO:0033700) | 4.32255170 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.31221774 |
| 66 | positive regulation of coagulation (GO:0050820) | 4.30672104 |
| 67 | lysine catabolic process (GO:0006554) | 4.28565356 |
| 68 | lysine metabolic process (GO:0006553) | 4.28565356 |
| 69 | negative regulation of complement activation (GO:0045916) | 4.27928837 |
| 70 | negative regulation of sterol transport (GO:0032372) | 4.25583501 |
| 71 | negative regulation of cholesterol transport (GO:0032375) | 4.25583501 |
| 72 | cholesterol efflux (GO:0033344) | 4.23719825 |
| 73 | amino-acid betaine metabolic process (GO:0006577) | 4.23522959 |
| 74 | glucuronate metabolic process (GO:0019585) | 4.18093482 |
| 75 | uronic acid metabolic process (GO:0006063) | 4.18093482 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10777993 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.10424683 |
| 78 | negative regulation of lipase activity (GO:0060192) | 4.10124533 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 4.09528344 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 4.08783182 |
| 81 | complement activation, classical pathway (GO:0006958) | 4.06441316 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05915942 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 4.04286939 |
| 84 | fibrinolysis (GO:0042730) | 4.02960719 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 4.02833570 |
| 86 | protein activation cascade (GO:0072376) | 4.02508904 |
| 87 | glycine metabolic process (GO:0006544) | 4.01358326 |
| 88 | bile acid and bile salt transport (GO:0015721) | 4.00877132 |
| 89 | acute-phase response (GO:0006953) | 3.99193256 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.98305542 |
| 91 | drug metabolic process (GO:0017144) | 3.95553510 |
| 92 | ethanol metabolic process (GO:0006067) | 3.94762593 |
| 93 | complement activation (GO:0006956) | 3.93951947 |
| 94 | cellular ketone body metabolic process (GO:0046950) | 3.93721552 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.87016485 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.86809797 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 3.84626401 |
| 98 | cofactor catabolic process (GO:0051187) | 3.83290184 |
| 99 | ethanol oxidation (GO:0006069) | 3.82117320 |
| 100 | lipoprotein metabolic process (GO:0042157) | 3.80219897 |
| 101 | aldehyde catabolic process (GO:0046185) | 3.77401185 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.76001530 |
| 103 | arginine metabolic process (GO:0006525) | 3.75935178 |
| 104 | plasma lipoprotein particle organization (GO:0071827) | 3.74162782 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68891139 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68891139 |
| 107 | regulation of plasminogen activation (GO:0010755) | 3.67041135 |
| 108 | oxidative demethylation (GO:0070989) | 3.66661004 |
| 109 | drug catabolic process (GO:0042737) | 3.64871741 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.64107867 |
| 111 | urate metabolic process (GO:0046415) | 3.63607933 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.61979390 |
| 113 | intestinal absorption (GO:0050892) | 3.61915576 |
| 114 | acetyl-CoA metabolic process (GO:0006084) | 3.60257721 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.59316669 |
| 116 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.58578276 |
| 117 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.58578276 |
| 118 | cellular glucuronidation (GO:0052695) | 3.57758055 |
| 119 | sterol homeostasis (GO:0055092) | 3.57651085 |
| 120 | cholesterol transport (GO:0030301) | 3.56301482 |
| 121 | sterol transport (GO:0015918) | 3.56301482 |
| 122 | acute inflammatory response (GO:0002526) | 3.55271727 |
| 123 | cytolysis (GO:0019835) | 3.54834921 |
| 124 | protein-lipid complex subunit organization (GO:0071825) | 3.51540603 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 3.50669241 |
| 126 | organic acid catabolic process (GO:0016054) | 3.50541286 |
| 127 | proline metabolic process (GO:0006560) | 3.50441471 |
| 128 | phenylpropanoid metabolic process (GO:0009698) | 3.40435816 |
| 129 | peptidyl-glutamic acid modification (GO:0018200) | 3.39825154 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 3.39746114 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.35033858 |
| 132 | negative regulation of humoral immune response (GO:0002921) | 3.34021838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.14696646 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03155098 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.58043478 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39822921 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.46886706 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.82409493 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25230164 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.14168978 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.69373992 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0231955 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90521426 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75720618 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72224231 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68590506 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53415856 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47466944 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45410609 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41273232 |
| 19 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38903851 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38566252 |
| 21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32484928 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19005492 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14659622 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12787633 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08892861 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05014548 |
| 27 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02953698 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02871633 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02331166 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00350663 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98044909 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93681699 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93164661 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93015542 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92671441 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89808659 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87000232 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84535319 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83491353 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82663728 |
| 41 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78347399 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76298401 |
| 43 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.76047796 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74230218 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74097921 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73386825 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72958180 |
| 48 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72544598 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71708773 |
| 50 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70926371 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70271287 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.69285417 |
| 53 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.68546229 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.67600730 |
| 55 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.67590527 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66638345 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66638345 |
| 58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65558255 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65429495 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64916695 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.63870138 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.63448162 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61419859 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61037935 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60215016 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.59288521 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58995765 |
| 68 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58985483 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58833377 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.58474037 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58152811 |
| 72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57868497 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.57716636 |
| 74 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.57264028 |
| 75 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57181209 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57055543 |
| 77 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56631170 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56558904 |
| 79 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56506943 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.56342256 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.55666524 |
| 82 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.55324951 |
| 83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55277866 |
| 84 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.54786484 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54358649 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54029141 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52896185 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52294694 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49794926 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.49738157 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49429958 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49377667 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.49055033 |
| 94 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48587731 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.48568576 |
| 96 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.48508107 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48344496 |
| 98 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.47840933 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.47510122 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47403253 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.46701767 |
| 102 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.46520776 |
| 103 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46355688 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46307097 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46275973 |
| 106 | AR_20517297_ChIP-Seq_VCAP_Human | 0.46266530 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.45560485 |
| 108 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.45176628 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44388887 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44241084 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44186202 |
| 112 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44012469 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43446632 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42957699 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42164694 |
| 116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.41812972 |
| 117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.41705788 |
| 118 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41542525 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.41273259 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40381020 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.40057194 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.38769663 |
| 123 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.38376008 |
| 124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38284582 |
| 125 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38250839 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38047631 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37868150 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37463664 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.37105634 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.37055859 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.37046442 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36293995 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.35428027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82420873 |
| 2 | MP0005360_urolithiasis | 6.92419977 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45884193 |
| 4 | MP0005365_abnormal_bile_salt | 5.89741384 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.90280066 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.46403723 |
| 7 | MP0003252_abnormal_bile_duct | 4.02860229 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.73379282 |
| 9 | MP0005083_abnormal_biliary_tract | 3.45957609 |
| 10 | MP0003195_calcinosis | 3.20371839 |
| 11 | MP0009840_abnormal_foam_cell | 3.19770696 |
| 12 | MP0003122_maternal_imprinting | 2.80661540 |
| 13 | MP0005332_abnormal_amino_acid | 2.74749596 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.69064324 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.68478837 |
| 16 | MP0000609_abnormal_liver_physiology | 2.27025930 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.22442014 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.97843720 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.81574340 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.79070281 |
| 21 | MP0000566_synostosis | 1.64621654 |
| 22 | MP0001915_intracranial_hemorrhage | 1.60292560 |
| 23 | MP0003868_abnormal_feces_composition | 1.59579950 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56810890 |
| 25 | MP0002254_reproductive_system_inflammat | 1.56036084 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.55472051 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.46403079 |
| 28 | MP0005451_abnormal_body_composition | 1.42505977 |
| 29 | MP0001764_abnormal_homeostasis | 1.39022871 |
| 30 | MP0003011_delayed_dark_adaptation | 1.36976464 |
| 31 | MP0000604_amyloidosis | 1.33854393 |
| 32 | MP0002089_abnormal_postnatal_growth/wei | 1.26404119 |
| 33 | MP0009697_abnormal_copulation | 1.26087018 |
| 34 | MP0005647_abnormal_sex_gland | 1.24444292 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.22700368 |
| 36 | MP0000598_abnormal_liver_morphology | 1.21194831 |
| 37 | MP0003123_paternal_imprinting | 1.20534317 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.19353453 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.11701086 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.10575020 |
| 41 | MP0009763_increased_sensitivity_to | 1.09379912 |
| 42 | MP0009764_decreased_sensitivity_to | 1.06844323 |
| 43 | MP0003690_abnormal_glial_cell | 1.02751711 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.97037076 |
| 45 | MP0009384_cardiac_valve_regurgitation | 0.96359040 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.94447438 |
| 47 | MP0003186_abnormal_redox_activity | 0.94379475 |
| 48 | MP0002971_abnormal_brown_adipose | 0.92500049 |
| 49 | MP0009642_abnormal_blood_homeostasis | 0.90048045 |
| 50 | MP0003329_amyloid_beta_deposits | 0.89171952 |
| 51 | MP0008469_abnormal_protein_level | 0.88784783 |
| 52 | MP0009379_abnormal_foot_pigmentation | 0.84937569 |
| 53 | MP0005409_darkened_coat_color | 0.82749499 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.81344258 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.81135613 |
| 56 | MP0003724_increased_susceptibility_to | 0.79917637 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.75797881 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.74921809 |
| 59 | MP0005334_abnormal_fat_pad | 0.74066225 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.73690055 |
| 61 | MP0003879_abnormal_hair_cell | 0.73086624 |
| 62 | MP0005670_abnormal_white_adipose | 0.72201820 |
| 63 | MP0005535_abnormal_body_temperature | 0.71103212 |
| 64 | MP0004272_abnormal_basement_membrane | 0.70273092 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.68570704 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.67460385 |
| 67 | MP0003075_altered_response_to | 0.67249197 |
| 68 | MP0001661_extended_life_span | 0.66627488 |
| 69 | MP0005408_hypopigmentation | 0.66122810 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.64954372 |
| 71 | MP0000579_abnormal_nail_morphology | 0.64926979 |
| 72 | MP0004130_abnormal_muscle_cell | 0.64636411 |
| 73 | MP0005266_abnormal_metabolism | 0.64051596 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 0.63677904 |
| 75 | MP0005257_abnormal_intraocular_pressure | 0.63192827 |
| 76 | MP0005166_decreased_susceptibility_to | 0.62699154 |
| 77 | MP0006054_spinal_hemorrhage | 0.62389138 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.61452007 |
| 79 | MP0005448_abnormal_energy_balance | 0.57829406 |
| 80 | MP0003121_genomic_imprinting | 0.56530620 |
| 81 | MP0003436_decreased_susceptibility_to | 0.56299790 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.56145916 |
| 83 | MP0004883_abnormal_blood_vessel | 0.54112231 |
| 84 | MP0002928_abnormal_bile_duct | 0.53372980 |
| 85 | MP0001756_abnormal_urination | 0.52161086 |
| 86 | MP0008874_decreased_physiological_sensi | 0.51614002 |
| 87 | MP0002933_joint_inflammation | 0.51142683 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.51116374 |
| 89 | MP0005023_abnormal_wound_healing | 0.50978695 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.50642988 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.50423425 |
| 92 | MP0002822_catalepsy | 0.49518758 |
| 93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.49127920 |
| 94 | MP0005395_other_phenotype | 0.47956178 |
| 95 | MP0009053_abnormal_anal_canal | 0.47213425 |
| 96 | MP0006082_CNS_inflammation | 0.45986262 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.45755218 |
| 98 | MP0003878_abnormal_ear_physiology | 0.44965372 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.44965372 |
| 100 | MP0000920_abnormal_myelination | 0.44924895 |
| 101 | MP0003632_abnormal_nervous_system | 0.44754896 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.44473769 |
| 103 | MP0003953_abnormal_hormone_level | 0.44160624 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.43094428 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.41299454 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.40853542 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.40546324 |
| 108 | MP0002132_abnormal_respiratory_system | 0.40170657 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.40096784 |
| 110 | MP0008873_increased_physiological_sensi | 0.37571771 |
| 111 | MP0001881_abnormal_mammary_gland | 0.36135821 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.35629532 |
| 113 | MP0005410_abnormal_fertilization | 0.34866370 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.34085332 |
| 115 | MP0003718_maternal_effect | 0.33822091 |
| 116 | MP0000249_abnormal_blood_vessel | 0.33645613 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 0.33473682 |
| 118 | MP0008872_abnormal_physiological_respon | 0.33401162 |
| 119 | MP0002128_abnormal_blood_circulation | 0.33155263 |
| 120 | MP0003115_abnormal_respiratory_system | 0.32952504 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.32629902 |
| 122 | MP0002168_other_aberrant_phenotype | 0.31465010 |
| 123 | MP0002092_abnormal_eye_morphology | 0.31040044 |
| 124 | MP0002970_abnormal_white_adipose | 0.30635811 |
| 125 | MP0001270_distended_abdomen | 0.30567979 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.29436877 |
| 127 | MP0003631_nervous_system_phenotype | 0.29387542 |
| 128 | MP0002796_impaired_skin_barrier | 0.29317802 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.28395649 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.28325919 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.28207520 |
| 132 | MP0009115_abnormal_fat_cell | 0.27414067 |
| 133 | MP0004381_abnormal_hair_follicle | 0.27253094 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.26807652 |
| 135 | MP0005164_abnormal_response_to | 0.26661435 |
| 136 | MP0001243_abnormal_dermal_layer | 0.26417863 |
| 137 | MP0003633_abnormal_nervous_system | 0.26220169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31435453 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.16807763 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.13824070 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.96224349 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.40308888 |
| 6 | Xanthomatosis (HP:0000991) | 6.39793348 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.89764335 |
| 8 | Complement deficiency (HP:0004431) | 5.78175012 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.56051536 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.31913560 |
| 11 | Spontaneous abortion (HP:0005268) | 4.95734002 |
| 12 | Joint hemorrhage (HP:0005261) | 4.85399142 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.65951177 |
| 14 | Epidermoid cyst (HP:0200040) | 4.64986061 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.44836618 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25105680 |
| 17 | Abnormality of complement system (HP:0005339) | 4.21362445 |
| 18 | Hyperammonemia (HP:0001987) | 4.10352082 |
| 19 | Hyperglycinemia (HP:0002154) | 4.06626902 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98774495 |
| 21 | Ketosis (HP:0001946) | 3.98314445 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97657690 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.95090558 |
| 24 | Fat malabsorption (HP:0002630) | 3.95083187 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.77751065 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.76162071 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.73723765 |
| 28 | Myocardial infarction (HP:0001658) | 3.72915197 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70695295 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63408216 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.63408216 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.55846848 |
| 33 | Hyperglycinuria (HP:0003108) | 3.46362167 |
| 34 | Amyloidosis (HP:0011034) | 3.20990054 |
| 35 | Purpura (HP:0000979) | 3.19377927 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.15723977 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.14524048 |
| 38 | Mitral stenosis (HP:0001718) | 3.11851294 |
| 39 | Gingival bleeding (HP:0000225) | 3.09550590 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 3.04389610 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.95529690 |
| 42 | Vascular calcification (HP:0004934) | 2.93394861 |
| 43 | Ketoacidosis (HP:0001993) | 2.92449603 |
| 44 | Steatorrhea (HP:0002570) | 2.92183626 |
| 45 | Skin nodule (HP:0200036) | 2.91876754 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.88944681 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.88309387 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.85379060 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.75272584 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.73602575 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67369744 |
| 52 | Thrombophlebitis (HP:0004418) | 2.66476942 |
| 53 | Malnutrition (HP:0004395) | 2.63311145 |
| 54 | Gout (HP:0001997) | 2.62688387 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.60887514 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.58960453 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.56980444 |
| 58 | Glomerulonephritis (HP:0000099) | 2.56902707 |
| 59 | Cholelithiasis (HP:0001081) | 2.54638554 |
| 60 | Osteomalacia (HP:0002749) | 2.53850307 |
| 61 | Acanthocytosis (HP:0001927) | 2.53218423 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.50527482 |
| 63 | Abnormal tarsal ossification (HP:0008369) | 2.45512745 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.43792592 |
| 65 | Metabolic acidosis (HP:0001942) | 2.41268795 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.41031033 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.40220052 |
| 68 | Arthropathy (HP:0003040) | 2.32358635 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.30362896 |
| 70 | Hypophosphatemic rickets (HP:0004912) | 2.29686846 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27870118 |
| 72 | Cholecystitis (HP:0001082) | 2.27113487 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.27113487 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25647363 |
| 75 | Spastic diplegia (HP:0001264) | 2.24334666 |
| 76 | Late onset (HP:0003584) | 2.24057175 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.24047447 |
| 78 | Pulmonary embolism (HP:0002204) | 2.22560789 |
| 79 | Neonatal onset (HP:0003623) | 2.19779171 |
| 80 | Esophageal varix (HP:0002040) | 2.19173698 |
| 81 | Irritability (HP:0000737) | 2.18990050 |
| 82 | Enlarged kidneys (HP:0000105) | 2.17701337 |
| 83 | Lethargy (HP:0001254) | 2.17030775 |
| 84 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16819010 |
| 85 | Poikilocytosis (HP:0004447) | 2.13451199 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08368521 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.08368521 |
| 88 | Menorrhagia (HP:0000132) | 2.08352949 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.06084405 |
| 90 | Abnormality of the gallbladder (HP:0005264) | 2.02811256 |
| 91 | Brushfield spots (HP:0001088) | 2.01350487 |
| 92 | Small epiphyses (HP:0010585) | 1.99785074 |
| 93 | Rickets (HP:0002748) | 1.98833333 |
| 94 | Flat acetabular roof (HP:0003180) | 1.98313185 |
| 95 | Opisthotonus (HP:0002179) | 1.96132754 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.96124142 |
| 97 | Joint swelling (HP:0001386) | 1.94783162 |
| 98 | Cerebral edema (HP:0002181) | 1.92777877 |
| 99 | Broad alveolar ridges (HP:0000187) | 1.91749114 |
| 100 | Pancreatitis (HP:0001733) | 1.91020992 |
| 101 | Bifid scrotum (HP:0000048) | 1.90784669 |
| 102 | Epistaxis (HP:0000421) | 1.89129533 |
| 103 | Vaginal fistula (HP:0004320) | 1.88894758 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.87964632 |
| 105 | Status epilepticus (HP:0002133) | 1.87949821 |
| 106 | Vomiting (HP:0002013) | 1.87889008 |
| 107 | Potter facies (HP:0002009) | 1.87333996 |
| 108 | Facial shape deformation (HP:0011334) | 1.87333996 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86241319 |
| 110 | Asymmetry of the thorax (HP:0001555) | 1.85762749 |
| 111 | Abnormality of glycolysis (HP:0004366) | 1.84644624 |
| 112 | Confusion (HP:0001289) | 1.84157996 |
| 113 | Reticulocytosis (HP:0001923) | 1.81513190 |
| 114 | Spastic paraparesis (HP:0002313) | 1.81190392 |
| 115 | Increased serum ferritin (HP:0003281) | 1.81001153 |
| 116 | Symptomatic seizures (HP:0011145) | 1.80374828 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.79873762 |
| 118 | Abnormal hand bone ossification (HP:0010660) | 1.76969370 |
| 119 | Stroke (HP:0001297) | 1.76263010 |
| 120 | Nephritis (HP:0000123) | 1.76126873 |
| 121 | Abnormal ossification of hand bones (HP:0005921) | 1.74394426 |
| 122 | Hyperglycemia (HP:0003074) | 1.73528710 |
| 123 | Hydroxyprolinuria (HP:0003080) | 1.71821104 |
| 124 | Abnormal delivery (HP:0001787) | 1.71177132 |
| 125 | Abnormality of the lumbar spine (HP:0100712) | 1.68910317 |
| 126 | Gangrene (HP:0100758) | 1.66819999 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 1.58874471 |
| 128 | Peritonitis (HP:0002586) | 1.58320522 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.56293360 |
| 130 | Fair hair (HP:0002286) | 1.56100298 |
| 131 | Hepatoblastoma (HP:0002884) | 1.55810188 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 1.51509880 |
| 133 | Submucous cleft hard palate (HP:0000176) | 1.50626614 |
| 134 | Broad palm (HP:0001169) | 1.48520706 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.48199556 |
| 136 | Widely patent fontanelles and sutures (HP:0004492) | 1.48157684 |
| 137 | Epiphyseal dysplasia (HP:0002656) | 1.47715000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.28170517 |
| 2 | FGFR4 | 5.18821902 |
| 3 | ERN1 | 4.96974202 |
| 4 | SIK1 | 4.73210420 |
| 5 | ERBB4 | 4.24846654 |
| 6 | WNK4 | 3.45314383 |
| 7 | TAOK3 | 3.32149420 |
| 8 | INSRR | 3.10139109 |
| 9 | PIK3CA | 2.75758656 |
| 10 | CDK12 | 2.75330885 |
| 11 | DAPK2 | 2.33645214 |
| 12 | TYRO3 | 2.29294512 |
| 13 | MAPK11 | 2.26969654 |
| 14 | MAPK15 | 2.19503719 |
| 15 | MAP2K4 | 2.17968625 |
| 16 | PDGFRA | 2.05113044 |
| 17 | PTK6 | 2.03414675 |
| 18 | FGFR1 | 1.97810150 |
| 19 | TYK2 | 1.83616899 |
| 20 | AKT3 | 1.71557553 |
| 21 | WNK1 | 1.66379734 |
| 22 | JAK2 | 1.58193434 |
| 23 | TRIB3 | 1.56973541 |
| 24 | MST1R | 1.56854727 |
| 25 | ERBB2 | 1.56744587 |
| 26 | PIK3CG | 1.41180899 |
| 27 | FGFR2 | 1.39618786 |
| 28 | LATS1 | 1.37934535 |
| 29 | EPHB1 | 1.35818715 |
| 30 | MAP3K7 | 1.28940215 |
| 31 | EIF2AK1 | 1.27487734 |
| 32 | PKN1 | 1.26782779 |
| 33 | PKN2 | 1.25123487 |
| 34 | DDR2 | 1.23565689 |
| 35 | KDR | 1.20998090 |
| 36 | JAK1 | 1.20916730 |
| 37 | EEF2K | 1.19775491 |
| 38 | EPHA4 | 1.19369317 |
| 39 | MAP3K2 | 1.15361672 |
| 40 | NTRK3 | 1.12598350 |
| 41 | EPHA3 | 1.09216907 |
| 42 | PRKAA2 | 1.04403601 |
| 43 | FLT3 | 1.03610880 |
| 44 | CAMK2G | 0.99781946 |
| 45 | NEK9 | 0.99585514 |
| 46 | ABL2 | 0.97981417 |
| 47 | MAP3K14 | 0.96831101 |
| 48 | MAPK4 | 0.90315634 |
| 49 | TBK1 | 0.89955364 |
| 50 | MAPK12 | 0.87576199 |
| 51 | MAPKAPK3 | 0.86721984 |
| 52 | SGK3 | 0.81869939 |
| 53 | RIPK1 | 0.81162203 |
| 54 | PRKCZ | 0.80935620 |
| 55 | MET | 0.79732724 |
| 56 | SGK1 | 0.77371079 |
| 57 | GRK6 | 0.77309549 |
| 58 | PRKACG | 0.77035230 |
| 59 | CSNK1E | 0.76324520 |
| 60 | CDK7 | 0.76212010 |
| 61 | FGR | 0.75998607 |
| 62 | CAMK1D | 0.75176518 |
| 63 | SGK2 | 0.72810946 |
| 64 | PINK1 | 0.71801777 |
| 65 | DYRK1B | 0.70558292 |
| 66 | RPS6KB1 | 0.70017652 |
| 67 | PRKAA1 | 0.68865057 |
| 68 | CDC42BPA | 0.68711598 |
| 69 | TIE1 | 0.66410084 |
| 70 | SGK494 | 0.66124212 |
| 71 | SGK223 | 0.66124212 |
| 72 | MAP3K13 | 0.64787356 |
| 73 | CSK | 0.62690903 |
| 74 | FRK | 0.61946976 |
| 75 | BCR | 0.60841145 |
| 76 | PTK2 | 0.60616616 |
| 77 | MAP2K3 | 0.59762128 |
| 78 | FGFR3 | 0.58566840 |
| 79 | GSK3A | 0.56130532 |
| 80 | MAPK7 | 0.55558041 |
| 81 | CAMK1G | 0.54145288 |
| 82 | PRKCQ | 0.52513390 |
| 83 | PDPK1 | 0.52189915 |
| 84 | PRKCG | 0.51484631 |
| 85 | EPHA2 | 0.51125178 |
| 86 | NLK | 0.50965041 |
| 87 | PAK3 | 0.50442253 |
| 88 | CDK6 | 0.49530512 |
| 89 | ICK | 0.49507895 |
| 90 | MAP3K10 | 0.48977450 |
| 91 | MAP2K6 | 0.48469092 |
| 92 | CSNK1D | 0.48107386 |
| 93 | BRD4 | 0.46815082 |
| 94 | MATK | 0.45656729 |
| 95 | IRAK3 | 0.45001407 |
| 96 | BRSK2 | 0.44762395 |
| 97 | MAP3K5 | 0.43717020 |
| 98 | CSNK1G1 | 0.43185538 |
| 99 | BRSK1 | 0.42953653 |
| 100 | SRC | 0.42839459 |
| 101 | NEK2 | 0.41963575 |
| 102 | TGFBR2 | 0.40077997 |
| 103 | RET | 0.40024794 |
| 104 | NEK1 | 0.39369138 |
| 105 | IGF1R | 0.38632516 |
| 106 | MTOR | 0.38366741 |
| 107 | CDK4 | 0.38135083 |
| 108 | STK39 | 0.37832150 |
| 109 | EGFR | 0.37686069 |
| 110 | CSF1R | 0.37146298 |
| 111 | CAMK4 | 0.36730661 |
| 112 | CSNK2A2 | 0.36017704 |
| 113 | MAP3K1 | 0.35946810 |
| 114 | BMX | 0.34977792 |
| 115 | KSR2 | 0.34018825 |
| 116 | CSNK1A1L | 0.33832882 |
| 117 | IKBKE | 0.33481205 |
| 118 | CSNK2A1 | 0.32940039 |
| 119 | CSNK1G2 | 0.32408200 |
| 120 | MAP3K3 | 0.32340408 |
| 121 | MARK2 | 0.31778945 |
| 122 | PDGFRB | 0.31772174 |
| 123 | NTRK1 | 0.30341088 |
| 124 | PRKCA | 0.30173236 |
| 125 | DAPK1 | 0.29268572 |
| 126 | SMG1 | 0.29003982 |
| 127 | MAP3K11 | 0.28940840 |
| 128 | NTRK2 | 0.28930043 |
| 129 | PRKACB | 0.28722613 |
| 130 | MAPK3 | 0.28127517 |
| 131 | MAP2K1 | 0.27864311 |
| 132 | PRKACA | 0.27336520 |
| 133 | CSNK1G3 | 0.26467788 |
| 134 | SIK2 | 0.26280794 |
| 135 | PRKCB | 0.25362312 |
| 136 | RPS6KA3 | 0.24569943 |
| 137 | MAP3K6 | 0.24162397 |
| 138 | PRKG1 | 0.24085521 |
| 139 | DAPK3 | 0.23806571 |
| 140 | PDK1 | 0.23584337 |
| 141 | LATS2 | 0.22421410 |
| 142 | ABL1 | 0.22331548 |
| 143 | GRK1 | 0.22253597 |
| 144 | PRKCH | 0.21921863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.63177878 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.06321489 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31141953 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.28062632 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09476657 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89539650 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.83751310 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66905344 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60525647 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55660361 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51171839 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21179349 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18967172 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10291733 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.09486120 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04929099 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94833941 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92867772 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88607186 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83236015 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79825497 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76224970 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72181794 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68554649 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67473372 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59812545 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59777958 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.59726699 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51642551 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51124721 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49641657 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49007402 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46843221 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45430026 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44551693 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41371753 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39464438 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.38142476 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34389793 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.30148033 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28332011 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21500000 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21188158 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21124470 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18124057 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16814431 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15612662 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15580564 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13085074 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08580584 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05174739 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01596959 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96115639 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95849136 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88549006 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86692857 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85527394 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85270992 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82332459 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81556228 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70760581 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67041124 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66434687 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65650581 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65426813 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58403441 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51408294 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.47390736 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47337294 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42365197 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39184558 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37069890 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.32037903 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31129488 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30404513 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28736486 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28263819 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23998421 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22180477 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20067056 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14574838 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.11403017 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09676804 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.08905548 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.02535163 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02313526 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00109173 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2240358 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2208426 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2146794 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2080594 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2020889 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1930152 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1904556 |
| 95 | Pertussis_Homo sapiens_hsa05133 | -0.1838199 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1666631 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.1523609 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1512810 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1433273 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1357121 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1344010 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1342676 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1268884 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1005383 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0970788 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0894210 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0778286 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0762339 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0489667 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0445987 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0084421 |

